St. Jude Children's Research Hospital is dedicated to improving the treatment of children with catastrophic illnesses, with a primary focus on cancer treatment and research. Investigators at St. Jude Children's Cancer Center are dedicated to the discovery of basic biological mechanisms in cancer pathogenesis and to improving the diagnosis and treatment for childhood cancers. Our scientists and physicians, whether engaged in discovery oriented, laboratory research or patient-focused clinical investigation, share a common dedication to improving the treatment and cure of children with cancer. Areas of strength in our Cancer Center include investigations of fundamental cell processes such as transcriptional regulation, cell signal transduction, and cell cycle control, elucidation of molecular mechanisms of oncogenesis including chromosomal translocations and tumor suppressor gene inactivation, molecular analysis of drug action, evaluation of innovative treatment strategies and the development of new therapeutic modalities. Hallmarks of our multidisciplinary research programs include a strong foundation of discovery-oriented, investigator-initiated research, and successful interactions among basic scientists and clinical investigators to translate new findings into innovative treatments to improve the outcomes of children with cancer. St. Jude Children's Cancer Center comprises six established programs (Signal Transduction, Hematological Malignancies, Molecular Oncogenesis, Solid Malignancies, Transplantation and Gene Therapy, and Viral Oncogenesis and Tumor Immunology) and two developing programs (Neurobiology and Brain Tumors, and Cancer Prevention and Control), supported by 18 Shared Resources that facilitate multidisciplinary research among our 141 Cancer Center members. As the only NCI-sponsored Cancer Center devoted solely to cancer in children, St. Jude is uniquely positioned to integrate basic and clinical research to elucidate the mechanisms and improve the treatment of childhood cancers.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
3P30CA021765-21S1
Application #
2867371
Study Section
Subcommittee G - Education (NCI)
Project Start
1977-09-01
Project End
2002-02-28
Budget Start
1998-03-18
Budget End
1999-02-28
Support Year
21
Fiscal Year
1998
Total Cost
Indirect Cost
Name
St. Jude Children's Research Hospital
Department
Type
DUNS #
067717892
City
Memphis
State
TN
Country
United States
Zip Code
38105
Scott, Jessica M; Li, Nan; Liu, Qi et al. (2018) Association of Exercise With Mortality in Adult Survivors of Childhood Cancer. JAMA Oncol 4:1352-1358
Rong, Yongqi; Bansal, Parmil K; Wei, Peng et al. (2018) Glycosylation of Cblns attenuates their receptor binding. Brain Res 1694:129-139
Levine, Jennifer M; Whitton, John A; Ginsberg, Jill P et al. (2018) Nonsurgical premature menopause and reproductive implications in survivors of childhood cancer: A report from the Childhood Cancer Survivor Study. Cancer 124:1044-1052
Li, Jian-Feng; Dai, Yu-Ting; Lilljebjörn, Henrik et al. (2018) Transcriptional landscape of B cell precursor acute lymphoblastic leukemia based on an international study of 1,223 cases. Proc Natl Acad Sci U S A 115:E11711-E11720
Sharma, Akshay; Kang, Guolian; Sunkara, Anusha et al. (2018) Haploidentical Donor Transplantation Using a Novel Clofarabine-containing Conditioning Regimen for Very High-risk Hematologic Malignant Neoplasms. J Pediatr Hematol Oncol 40:e479-e485
Waszak, Sebastian M; Northcott, Paul A; Buchhalter, Ivo et al. (2018) Spectrum and prevalence of genetic predisposition in medulloblastoma: a retrospective genetic study and prospective validation in a clinical trial cohort. Lancet Oncol 19:785-798
Zheng, Wenting; O'Hear, Carol E; Alli, Rajshekhar et al. (2018) PI3K orchestration of the in vivo persistence of chimeric antigen receptor-modified T cells. Leukemia 32:1157-1167
Heikamp, Emily B; Pui, Ching-Hon (2018) Next-Generation Evaluation and Treatment of Pediatric Acute Lymphoblastic Leukemia. J Pediatr 203:14-24.e2
Sadighi, Zsila S; Curtis, Elizabeth; Zabrowksi, Jennifer et al. (2018) Neurologic impairments from pediatric low-grade glioma by tumor location and timing of diagnosis. Pediatr Blood Cancer 65:e27063
Wierdl, Monika; Tsurkan, Lyudmila; Chi, Liying et al. (2018) Targeting ALK in pediatric RMS does not induce antitumor activity in vivo. Cancer Chemother Pharmacol 82:251-263

Showing the most recent 10 out of 6764 publications